What is the recommended management of scabies, including first‑line topical permethrin 5 % cream for patients ≥2 months old, alternative sulfur ointment for infants <2 months or pregnant/lactating women, and indications for oral ivermectin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Scabies

Permethrin 5% cream applied from the neck down for 8–14 hours (typically overnight) is the first-line treatment for uncomplicated scabies in patients ≥2 months old, with oral ivermectin 200 μg/kg (repeated in 2 weeks) serving as an equally effective alternative or for institutional outbreaks. 1

First-Line Treatment Options

Topical Permethrin 5% Cream

  • Apply to all areas of the body from the neck down, leave on for 8–14 hours, then wash off; a single application is generally curative 1
  • In infants and young children ≤2 years, apply to the entire body including scalp, hairline, forehead, temples, and neck—not just neck-down as in adults 2
  • Permethrin is the preferred agent for pregnant and lactating women due to limited safety data for ivermectin in these populations 3, 1
  • For infants <2 months, permethrin remains first-line with 100% complete resolution rates in this age group 4

Oral Ivermectin

  • Dose: 200 μg/kg orally, repeated in 2 weeks 1, 5
  • Must be taken with food to increase bioavailability and epidermal penetration 1, 5
  • Contraindicated in children weighing <15 kg or <10 years old due to potential blood-brain barrier penetration and neurotoxicity 3, 2
  • No dosage adjustment needed for renal impairment 5
  • Particularly useful when topical application is impractical (e.g., institutional outbreaks, extensive dermatitis) 1, 6

Alternative Topical Agents (when permethrin unavailable or fails)

  • Sulfur 6% ointment: Applied nightly for 3 consecutive nights; safest option for infants <2 months 1, 7
  • Benzyl benzoate 25%: ~87% cure rate but causes burning sensation in ~43% of patients 2
  • Crotamiton 10% cream: Applied nightly for 2 nights, ~60% cure rate versus ~89% for permethrin 2

Special Populations and Clinical Scenarios

Crusted (Norwegian) Scabies

  • Requires aggressive combination therapy: Topical permethrin 5% cream applied daily for 7 days, then twice weekly until cure, PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15 1, 2
  • Single-application permethrin or single-dose ivermectin alone will fail due to massive mite burden (thousands to millions of mites) and thick crusts that prevent drug penetration 1
  • Mandatory specialist consultation for management 3, 1
  • Common in immunocompromised patients (HIV, debilitated, malnourished) who require closer monitoring 3, 1

Pregnant and Lactating Women

  • Permethrin 5% cream is the preferred treatment 3, 1
  • Ivermectin is classified as "low risk" based on limited human data but permethrin remains first choice 3, 5

Infants <2 Months

  • Permethrin 5% cream is recommended; apply to entire body including head and neck 2
  • Sulfur 6% ointment is the safest alternative if permethrin is unavailable 1, 7
  • Ivermectin is absolutely contraindicated due to neurotoxicity risk 2
  • Lindane must never be used 2

Contact and Environmental Management

Simultaneous Treatment of All Contacts

  • All household members, sexual partners, and close personal contacts within the preceding month must be treated simultaneously, even if asymptomatic 3, 1
  • Scabies has a 4–6 week incubation period during which infected persons remain contagious despite being asymptomatic—untreated contacts are the most common cause of treatment failure 1
  • Treating only the symptomatic index case permits asymptomatic household members to reinfect the patient within days to weeks 1

Environmental Decontamination

  • Machine-wash and dry all bedding, clothing, and towels on hot cycles, or dry-clean them 3, 1
  • Alternatively, remove items from body contact for at least 72 hours (mites cannot survive off-host beyond this period) 1, 2
  • Fumigation of living areas is unnecessary 1, 2

Follow-Up and Management of Persistent Symptoms

Expected Post-Treatment Course

  • Pruritus and rash may persist for up to 2 weeks after successful treatment due to allergic dermatitis—this does NOT indicate treatment failure 3, 1
  • Topical corticosteroids (e.g., triamcinolone) and oral antihistamines can relieve post-treatment pruritus, but only AFTER confirming no live mites are present 1
  • Do not apply corticosteroids during active treatment, as they may suppress the inflammatory response that helps identify active infestation 1

Retreatment Criteria

  • Consider retreatment only after 2 weeks if symptoms persist beyond this period OR live mites are observed 3, 1
  • Use an alternative regimen (switch between permethrin and ivermectin) for those who do not respond to initial treatment 3, 1
  • Premature retreatment within the first 2 weeks based solely on persistent itching should be avoided 1

Causes of Treatment Failure

  • Improper application of topical agents (inadequate coverage, insufficient contact time) 8
  • Failure to repeat ivermectin dose after 2 weeks 5, 8
  • Reinfection from untreated contacts or contaminated fomites 3
  • Incomplete decontamination of bedding and clothing 3, 8
  • Absence of written instructions explaining treatment modalities 8

Institutional Outbreaks

  • Treat the entire at-risk population simultaneously—control can only be achieved by treating everyone 3, 1
  • Mass oral ivermectin administration is recommended for ease of delivery in nursing homes, hospitals, and residential facilities 3, 1, 6
  • Manage outbreaks in consultation with a specialist 3, 1

Treatments to Avoid

Lindane

  • Never use lindane in children <10 years, pregnant or lactating women, or persons with extensive dermatitis due to risk of neurotoxicity (seizures) and aplastic anemia 3, 1, 2
  • Applying lindane after bathing increases systemic absorption and toxicity 1, 2
  • Lindane has the highest toxicity profile among scabicidal agents and is strongly discouraged 1

Common Pitfalls to Avoid

  • Failure to treat asymptomatic sexual partners and household contacts simultaneously—the most frequent cause of reinfection 1
  • Forgetting the second dose of ivermectin at 2 weeks—mandatory due to limited ovicidal activity 5
  • Taking ivermectin on an empty stomach—markedly reduces absorption 1, 5
  • Expecting immediate resolution of symptoms—post-treatment pruritus is normal for up to 2 weeks 3, 1
  • Using single-application permethrin for crusted scabies—will fail due to massive mite burden 1
  • Inadequate application of topical permethrin (missing finger webs, genitals, under nails) 8

References

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Scabies Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ivermectin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Treatment of scabies].

Atencion primaria, 2022

Research

Scabies: Epidemiology, Diagnosis, and Treatment.

Deutsches Arzteblatt international, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.